Home/Filings/4/0001209191-17-044901
4//SEC Filing

CATALYST BIOSCIENCES, INC. 4

Accession 0001209191-17-044901

$GYRECIK 0001124105operating

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 4:47 PM ET

Size

5.3 KB

Accession

0001209191-17-044901

Insider Transaction Report

Form 4
Period: 2017-07-11
Payne Fletcher
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-07-11+75,00075,000 total
    Exercise: $4.63Exp: 2027-07-11Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The Option vests monthly over a period of four years commencing June 15, 2017.

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001124105

Filing Metadata

Form type
4
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:47 PM ET
Size
5.3 KB